Chapter 3 - Pulmonary cryptococcosis;Capítulo 3 - Criptococose pulmonar

Jornal Brasileiro de Pneumologia

Volumn 35, Issue 11, 2009, Pages 1136-1144

  Severo, Cecília Bittencourt ^a   Gazzoni, Alexandra Flávia ^b   Severo, Luiz Carlos ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Acquired immunodeficiency syndrome; Amphotericin B; Cryptococcus neoformans; Fluconazole; Pneumonia

Indexed keywords

EID: 72049106938     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132009001100012     Document Type: Article

References (57)

1. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20(3):507-44, v-vi.
2. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA. 2004;101(49):17258-63.
3. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol. 1999;37(3):838-40.
4. Kwon-Chung KJ, Bennett JE, Rhodes JC. Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek. 1982;48(1):25-38.
5. Subramanian S, Mathai D. Clinical manifestations and management of cryptococcal infection. J Postgrad Med. 2005;51 Suppl 1:S21-6.
6. Capone D, Gonçalves AJ, Andrade EM, Peyneau A, Wanke B, Montessi J, et al. Criptococose pulmonar por Cryptococcus neoformans não capsulado. J Bras Med. 1986;50(5): 67, 69-70.
7. Severo LC. Criptococose: duas doenças? [thesis]. Porto Alegre: Fundação Faculdade Federal de Ciências Médicas de Porto Alegre; 1993
8. Severo LC, Londero AT, Martins SC, Reolon M, Geyer RG. Provável criptococose pulmonar causada por Cryptococcus neoformans não-capsulado. Rev Inst Med Trop Sao Paulo. 1981;23(6):283-6.
9. Williamson JD, Silverman JF, Mallak CT, Christie JD. Atypical cytomorphologic appearance of Cryptococcus neoformans: a report of five cases. Acta Cytol. 1996;40(2):363-70.
10. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984;120(1):123-30.
11. Cohen J, Perfect JR, Durack DT. Cryptococcosis and the basidiospore. Lancet. 1982;1(8284):1301.
12. Zimmer BL, Hempel HO, Goodman NL. Pathogenicity of the basidiospores of Filobasidiella neoformans. Mycopathologia. 1984;85(3):149-53.
13. Cohen J. The pathogenesis of cryptococcosis. J Infect. 1982;5(2):109-16.
14. Littman ML, Schneierson SS. Cryptococcus neoformans in pigeon excreta in New York City. Am J Hyg. 1959;69(1):49-59.
15. Kwon-Chung KJ, Kozel TR, Edman JC, Polacheck I, Ellis D, Shinoda T, et al. Recent advances in biology and immunology of Cryptococcus neoformans. J Med Vet Mycol. 1992;30 Suppl 1:133-42.
16. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995;8(4):515-48.
17. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis. 1999;179(2):449-54.
18. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis. 2003;36(6):789-94.
19. Dromer F, Mathoulin-Pélissier S, Fontanet A, Ronin O, Dupont B, Lortholary O, et al. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS. 2004;18(3):555-62.
20. Friedman GD, Jeffrey Fessel W, Udaltsova NV, Hurley LB. Cryptococcosis: the 1981-2000 epidemics. Mycoses. 2005;48(2):122-5.
21. Hage CA, Wood KL, Winer-Muram HT, Wilson SJ, Sarosi G, Knox KS. Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy. Chest. 2003;124(6):2395-7.
22. Soares MC, Paula CR, Dias AL, Caseiro MM, Costa SO. Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47(1):31-6.
23. Pappalardo MC, Melhem MS. Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop Sao Paulo. 2003;45(6):299-305.
24. Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol. 1977;105(6):582-6.
25. Jenney A, Pandithage K, Fisher DA, Currie BJ. Cryptococcus infection in tropical Australia. J Clin Microbiol. 2004;42(8):3865-8.
26. Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RC, et al. Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol. 2003;41(1):73-7.
27. Pasqualotto AC, Bittencourt Severo C, de Mattos Oliveira F, Severo LC. Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev Iberoam Micol. 2004;21(3):143-6.
28. Severo LC, de Mattos Oliveira F, Londero AT. Cryptococcosis due to Cryptococcus neoformans var. gattii in Brazilian patients with AIDS. Report of three cases. Rev Iberoam Micol. 1999;16(3):152-4.
29. Garau M, del Palacio A. Cryptococcus neoformans arthritis in a renal transplant recipient [Article in Spanish]. Rev Iberoam Micol. 2002;19(3):186-9.
30. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am. 2002;16(4):837-74, v-vi.
31. Severo LC, Berta-E-Zardo I, Londero AT. Cutaneous cryptococcosis due to Cryptococcus neoformans var. gattii. Rev Iberoam Micol. 2001;18(4):200-1.
32. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31(2):499-508.
33. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21(1):28-34; discussion 35-6.
34. Nadrous HF, Antonios VS, Terrell CL, Ryu JH. Pulmonary cryptococcosis in nonimmunocompromised patients. Chest. 2003;124(6):2143-7.
35. Lortholary O, Nunez H, Brauner MW, Dromer F. Pulmonary cryptococcosis. Semin Respir Crit Care Med. 2004;25(2):145-57.
36. Su CT, Chen LK, Tsai YF, Kuo CJ, Lu CL, Chen HY. Disseminated cryptococcosis with pulmonary and marrow involvement mimicking radiological features of malignancy. J Chin Med Assoc. 2004;67(2):89-92.
37. Oliveira Fde M, Severo CB, Guazzelli LS, Severo LC. Cryptococcus gattii fungemia: report of a case with lung and brain lesions mimicking radiological features of malignancy. Rev Inst Med Trop Sao Paulo. 2007;49(4):263-5.
38. Mitchell DH, Sorrell TC. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis. 1992;14(5):1142-4.
39. Chang WC, Tzao C, Hsu HH, Lee SC, Huang KL, Tung HJ, et al. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest. 2006;129(2):333-40.
40. Chandler FW, Watts JC. Cryptococcosis. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, editors. Pathology of infectious diseases, Stamford: Appleton & Lange, 1997. p. 989-97.
41. Gazzoni AF, Pegas KL, Severo LC. Histopathological techniques for diagnosing cryptococcosis due to capsule-deficient Cryptococcus: case report [Article in Portuguese]. Rev Soc Bras Med Trop. 2008;41(1):76-8.
42. Schwartz DA. Characterization of the biological activity of Cryptococcus infections in surgical pathology. The Budding Index and Carminophilic Index. Ann Clin Lab Sci. 1988;18(5):388-97.
43. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington: ASM Press; 1998.
44. Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol. 1996;27(8):839-47.
45. McDonnell JM, Hutchins GM. Pulmonary cryptococcosis. Hum Pathol. 1985;16(2):121-8.
46. Shibuya K, Hirata A, Omuta J, Sugamata M, Katori S, Saito N, et al. Granuloma and cryptococcosis. J Infect Chemother. 2005;11(3):115-22.
47. Chong PY, Panabokke RG, Chew KH. Omental cryptococcoma. An unusual presentation of cryptococcosis. Arch Pathol Lab Med. 1986;110(3):239-41.
48. Lehmann PF, Morgan RJ, Freimer EH. Infection with Cryptococcus neoformans var. gattii leading to a pulmonary cryptococcoma and meningitis. J Infect. 1984;9(3):301-6.
49. Alfonso F, Gallo L, Winkler B, Suhrland MJ. Fine needle aspiration cytology of peripheral lymph node cryptococcosis. A report of three cases. Acta Cytol. 1994;38(3):459-62.
50. Gal AA, Koss MN, Hawkins J, Evans S, Einstein H. The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1986;110(6):502-7.
51. Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Muller NL, King TE. Lung Infections. In: Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Muller NL, King TE, editors. Non-Neoplastic disorders of the lower respiratory tract. Washington: American Registry of Pathology; 2002. p. 600-5.
52. Gutierrez F, Fu YS, Lurie H. Cryptococcosis histologically resembling histoplasmosis. A light and electron microscopical study. Arch Pathol. 1975;99(7):347-52.
53. Harding SA, Scheld WM, Feldman PS, Sande MA. Pulmonary infection with capsule-deficient cryptococcus neoformans. Virchows Arch A Pathol Anat Histol. 1979;382(1):113-8.
54. Farmer SG, Komorowski RA. Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol. 1973;96(6):383-7.
55. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol. 1982;15(3):535-7.
56. Kauffman CA, Bergman AG, Severance PJ, McClatchey KD. Detection of cryptococcal antigen. Comparison of two latex agglutination tests. Am J Clin Pathol. 1981;75(1):106-9.
57. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Clin Infect Dis. 2000;30 Suppl 1:S29-65.